Kite shows data from ZUMA-3 Study of KTE-C19 in patients with certain Acute Lymphoblastic Leukemia
Kite, a Gilead Company, announced updated results from the ongoing Phase 1/2 ZUMA-3 study of KTE-C19, a CD19 chimeric antigen…
Pharmaceuticals, Biotechnology and Life Sciences
Kite, a Gilead Company, announced updated results from the ongoing Phase 1/2 ZUMA-3 study of KTE-C19, a CD19 chimeric antigen…
Alexion Pharmaceuticals’s data from two Phase 1b/2 studies of ALXN1210, the company’s investigational long-acting C5 complement inhibitor, in patients with…
The U.S. Food and Drug Administration (FDA) said on Monday in an announcement that an adult smoking cessation education campaign…
Premaitha Health, a leading international molecular diagnostics group focused on non-invasive prenatal testing (NIPT), announces further expansion of its European…
Eli Lilly said on Monday that Kimberly Blackwell, M.D., one of the USA’s leading breast cancer researchers, will join Lilly Oncology as…
Eli Lilly said on Monday that the U.S. Food and Drug Administration (FDA) has accepted a Biologics License Application (BLA) to review…
Juno Therapeutics, a biopharmaceutical company developing innovative cellular immunotherapies for the treatment of cancer, and Celgene Corporation have additional data from the…
SOBI and Bioverativ on Monday announced the results of a new post-hoc longitudinal analysis demonstrating that individualised dosing with extended…
People with either type 1 or type 2 diabetes treated with Tresiba had fewer episodes of low blood sugar (hypoglycaemia) compared…
We are very proud to be partnering with the ProcureCon Pharma 2018, the only event in Europe for senior pharma…